Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (ISBN ) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (ISBN ) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Preventing Medication Errors: Quality Chasm Series (ISBN ) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (ISBN ) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• The Ethical Conduct of Clinical Research Involving Children (ISBN ) Marilyn J. Field and Richard E. Berman, Editors, Committee on Clinical Research Involving Children


• Addressing the Barriers to Pediatric Drug Development: Workshop Summary (ISBN ) Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (ISBN ) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Emergency Care for Children: Growing Pains (ISBN ) Committee on the Future of Emergency Care in the United States Health System


• Rational Therapeutics for Infants and Children:Workshop Summary (ISBN ) Sumner Yaffe, M.D., Editor; Ronald W. Estabrook, Peter Bouxsein, Sarah Pitluck, Jonathan R. Davis, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (ISBN ) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Making Better Drugs for Children with Cancer (ISBN ) Peter C. Adamson, Susan L Weiner, Joseph V. Simone, and Hellen Gelband, Editors, Committee on Shortening the Time Line for New Cancer Treatments, Institute of Medicine and the National Research Council


• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (ISBN ) Jim E. Riviere and Gillian J. Buckley, Editors; Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries; Board on Global Health; Board on Health Sciences Policy; Institute of Medicine


• Health Care Comes Home: The Human Factors (ISBN ) Committee on the Role of Human Factors in Home Health Care; National Research Council


• Innovation and Invention in Medical Devices: Workshop Summary (ISBN ) Kathi E. Hanna, Frederick J. Manning, Peter Bouxsein, and Andrew Pope, Editors, Based on a Workshop of the Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Board on Health Sciences Policy


• Food and Drug Administration Advisory Committees (ISBN ) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• Informing the Future: Critical Issues in Health, Fourth Edition (ISBN )


• Informing the Future: Critical Issues in Health, Third Edition (ISBN )


• The Safe Use Initiative and Health Literacy: Workshop Summary (ISBN ) Cori Vancheri, Rapporteur; Roundtable on Health Literacy; Institute of Medicine


• Assessing Medical Technologies (ISBN ) Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (ISBN ) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Ethical Issues in Studying the Safety of Approved Drugs:A Letter Report (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• The Role of Human Factors in Home Health Care:Workshop Summary (ISBN ) Steve Olson, Rapporteur; Committee on the Role of Human Factors in Home Healthcare; National Research Council


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Developing New Contraceptives:Obstacles and Opportunities (ISBN ) Committee on Contraceptive Development, National Research Council and Institute of Medicine